Cannabis and adolescent brain development

被引:229
作者
Lubman, Dan I. [1 ]
Cheetham, Ali [1 ]
Yuecel, Murat [2 ,3 ,4 ]
机构
[1] Monash Univ, Turning Point, Eastern Hlth & Eastern Hlth Clin Sch, Clayton, Vic 3800, Australia
[2] Univ Melbourne, Dept Psychiat, Melbourne Neuropsychiat Ctr, Melbourne, Vic 3010, Australia
[3] Melbourne Hlth, Melbourne, Vic, Australia
[4] Monash Univ, Sch Psychol Sci, Monash Clin & Imaging Neurosci, Melbourne, Vic 3004, Australia
基金
澳大利亚国家健康与医学研究理事会;
关键词
Cannabis; Adolescence; Brain development; Endocannabinoid; Cognition; Mental illness; PRENATAL MARIJUANA EXPOSURE; CEREBRAL-BLOOD-FLOW; HIPPOCAMPAL ENDOCANNABINOID SYSTEM; WHITE-MATTER ABNORMALITIES; CULTURED CORTICAL-NEURONS; ANTERIOR CINGULATE CORTEX; MESSENGER-RNA EXPRESSION; LONG-TERM POTENTIATION; CENTRAL-NERVOUS-SYSTEM; AGE-OF-ONSET;
D O I
10.1016/j.pharmthera.2014.11.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Heavy cannabis use has been frequently associated with increased rates of mental illness and cognitive impairment, particularly amongst adolescent users. However, the neurobiological processes that underlie these associations are still not well understood. In this review, we discuss the findings of studies examining the acute and chronic effects of cannabis use on the brain, with a particular focus on the impact of commencing use during adolescence. Accumulating evidence from both animal and human studies suggests that regular heavy use during this period is associated with more severe and persistent negative outcomes than use during adulthood, suggesting that the adolescent brain may be particularly vulnerable to the effects of cannabis exposure. As the endocannabinoid system plays an important role in brain development, it is plausible that prolonged use during adolescence results in a disruption in the normative neuromaturational processes that occur during this period. We identify synaptic pruning and white matter development as two processes that may be adversely impacted by cannabis exposure during adolescence. Potentially, alterations in these processes may underlie the cognitive and emotional deficits that have been associated with regular use commencing during adolescence. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:1 / 16
页数:16
相关论文
共 302 条
[1]   Short- and Long-Term Cognitive Effects of Chronic Cannabinoids Administration in Late-Adolescence Rats [J].
Abush, Hila ;
Akirav, Irit .
PLOS ONE, 2012, 7 (02)
[2]   Cannabinoid Receptor Genotype Moderation of the Effects of Childhood Physical Abuse on Anhedonia and Depression [J].
Agrawal, Arpana ;
Nelson, Elliot C. ;
Littlefield, Andrew K. ;
Bucholz, Kathleen K. ;
Degenhardt, Louisa ;
Henders, Anjali K. ;
Madden, Pamela A. F. ;
Martin, Nicholas G. ;
Montgomery, Grant W. ;
Pergadia, Michele L. ;
Sher, Kenneth J. ;
Heath, Andrew C. ;
Lynskey, Michael T. .
ARCHIVES OF GENERAL PSYCHIATRY, 2012, 69 (07) :732-740
[3]   Changing incidence of psychotic disorders among the young in Zurich [J].
Ajdacic-Gross, Vladeta ;
Lauber, Christoph ;
Warnke, Inge ;
Haker, Helene ;
Murray, Robin M. ;
Roessler, Wulf .
SCHIZOPHRENIA RESEARCH, 2007, 95 (1-3) :9-18
[4]   Psychosis-inducing effects of cannabis are related to both childhood abuse and COMT genotypes [J].
Alemany, S. ;
Arias, B. ;
Fatjo-Vilas, M. ;
Villa, H. ;
Moya, J. ;
Ibanez, M. I. ;
Ortet, G. ;
Gasto, C. ;
Fananas, L. .
ACTA PSYCHIATRICA SCANDINAVICA, 2014, 129 (01) :54-62
[5]   Differential role of the hippocampal endocannabinoid system in the memory consolidation and retrieval mechanisms [J].
Alvares, Lucas De Oliveira ;
Genro, Bruna Pasqualini ;
Diehl, Felipe ;
Quillfeldt, Jorge A. .
NEUROBIOLOGY OF LEARNING AND MEMORY, 2008, 90 (01) :1-9
[6]   Neuroprotective Effects of the Nonpsychoactive Cannabinoid Cannabidiol in Hypoxic-Ischemic Newborn Piglets [J].
Alvarez, Francisco J. ;
Lafuente, Hector ;
Rey-Santano, M. Carmen ;
Mielgo, Victoria E. ;
Gastiasoro, Elena ;
Rueda, Miguel ;
Pertwee, Roger G. ;
Castillo, Ana I. ;
Romero, Julian ;
Martinez-Orgado, Jose .
PEDIATRIC RESEARCH, 2008, 64 (06) :653-658
[7]   Long-term consequences of a single treatment of mice with an ultra-low dose of Δ9-tetrahydrocannabinol (THC) [J].
Amal, Haitham ;
Fridman-Rozevich, Lilach ;
Senn, Roey ;
Strelnikov, Anastasia ;
Gafni, Mikhal ;
Keren, Ora ;
Sarne, Yosef .
BEHAVIOURAL BRAIN RESEARCH, 2010, 206 (02) :245-253
[8]  
Amen DG, 1998, J PSYCHOACTIVE DRUGS, V30, P209
[9]  
[Anonymous], CANNABIS ENDOCANNABI
[10]  
[Anonymous], PLOS ONE